These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Acquired neuromuscular weakness and early mobilization in the intensive care unit. Lipshutz AK; Gropper MA Anesthesiology; 2013 Jan; 118(1):202-15. PubMed ID: 22929731 [TBL] [Abstract][Full Text] [Related]
12. [Intensive Care Unit-Acquired Weakness]. Siao SF; Yen YH; Yu YF; Zong SL; Chen CC Hu Li Za Zhi; 2020 Jun; 67(3):6-13. PubMed ID: 32495324 [TBL] [Abstract][Full Text] [Related]
13. Functional ability and quality of life in critical illness survivors with intensive care unit acquired weakness: A secondary analysis of a randomised controlled trial. Eggmann S; Luder G; Verra ML; Irincheeva I; Bastiaenen CHG; Jakob SM PLoS One; 2020; 15(3):e0229725. PubMed ID: 32131082 [TBL] [Abstract][Full Text] [Related]
14. [Research progress in diagnosis and evaluation of intensive care unit-acquired weakness]. Yang F; Fang F Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Dec; 33(12):1533-1536. PubMed ID: 35131027 [TBL] [Abstract][Full Text] [Related]
15. Fitness and mobility training in patients with Intensive Care Unit-acquired muscle weakness (FITonICU): study protocol for a randomised controlled trial. Mehrholz J; Thomas S; Burridge JH; Schmidt A; Scheffler B; Schellin R; Rückriem S; Meißner D; Mehrholz K; Sauter W; Bodechtel U; Elsner B Trials; 2016 Nov; 17(1):559. PubMed ID: 27881152 [TBL] [Abstract][Full Text] [Related]
16. Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis. Ozdemir M; Bomkamp MP; Hyatt HW; Smuder AJ; Powers SK Cells; 2022 Dec; 11(24):. PubMed ID: 36552769 [TBL] [Abstract][Full Text] [Related]
17. Intensive care unit-acquired weakness: Questions the clinician should ask. Tortuyaux R; Davion JB; Jourdain M Rev Neurol (Paris); 2022; 178(1-2):84-92. PubMed ID: 34998522 [TBL] [Abstract][Full Text] [Related]
18. Poor physical recovery after critical illness: incidence, features, risk factors, pathophysiology, and evidence-based therapies. Boelens YFN; Melchers M; van Zanten ARH Curr Opin Crit Care; 2022 Aug; 28(4):409-416. PubMed ID: 35796071 [TBL] [Abstract][Full Text] [Related]
19. The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of weakness and neuromuscular dysfunction. Hough CL; Needham DM Curr Opin Crit Care; 2007 Oct; 13(5):489-96. PubMed ID: 17762224 [TBL] [Abstract][Full Text] [Related]
20. Acute neuromuscular weakness in the intensive care unit. Maramattom BV; Wijdicks EF Crit Care Med; 2006 Nov; 34(11):2835-41. PubMed ID: 16932235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]